Electronic cigarettes.

Any parent should know that.

Unfortunately, modern statistics shows an increase in smoking of electronic cigarettes among children and teenagers, and the number of severe lung diseases is increasing.

What is evaporation?

It is inhalation of vapor from electronic cigarettes that comes from liquids. These cigarettes contain high levels of nicotine, which increases the risk of heart and lung disease.

Trends.

Recently, there has been a trend of increasing lung diseases associated with smoking electronic cigarettes. This is evidenced by CDC statistics and the U.S. Food and Drug Administration (FDA).

The CDC and FDA investigate the brand and types of electronic cigarettes used and analyze samples for nicotine, THC or other chemicals or ingredients that may cause disease.

What are the symptoms of lung disease?

For example, the most common symptoms are difficulty breathing, chest pain, and coughing. Rare symptoms include vomiting, diarrhoea, stomach problems, fatigue or fever.

Take care of your children.

If your children have any similar symptoms, be sure to hurry to see a doctor.

Also, remember to be a good role model and talk to your children about the dangers of smoking and the possible sad consequences of smoking.

Support as long as the young person tries to quit swimming. Electronic cigarettes are addictive and quitting can be difficult.




AUTOMATIC GENERIC SUBSTITUTION

Automatic generic substitution (AGS) is the term for a scheme proposed by the Department of Health (DH) in 2009. AGS would have allowed pharmacists to dispense a generic version of a medication (a version with the same active ingredient), even if the doctor had written the prescription for a specific brand.


The Department of Health says no to AGS

After a consultation that resulted in written responses from 423 organisations and individuals, the DH announced, on 14 October 2010, that it had stopped plans to introduce AGS by pharmacists. The DH decided that concerns over patient safety were sufficiently grounded in fact and that it was therefore not appropriate to implement AGS.1

 

Taking Action Works!

The DH decided not to proceed with AGS as it reviewed the responses to the consultation and agreed that AGS was too great a risk to patients.

The correct use of medicines is important for achieving this goal, and the role of pharmacists is fully acknowledged in helping to achieve this. However, it is important that the relevant MHRA legislation is worded accurately to ensure that generic substitution or even therapeutic substitution by pharmacists is not inadvertently embedded in medicines legislation.

Thank you to those that acted last time - we are delighted that the DH listened to us and acted on our concerns.

Hexomedine

Parasinus

Cancer

Losing the right medication for the right patient

Norgine position paper

Norgine discussion. There is no Substitute

Outcome of DoH consultation on generic substitution

14th October 2010

Contacts

Julie Hornby Winfield
Norgine
JWinfield@norgine.com
+44 (0)1895 826642

Jennifer Garratt
Burson-Marsteller
Jennifer.Garratt@bm.com
+44 (0) 207 300 6240

References

  • The proposals to implement 'generic substitution' in primary care, further to the Pharmaceutical Price Regulation Scheme (PPRS) 2009. Response to the consultation.
  • MHRA Consolidation and review of UK medicines legislation. 25 October 2011. http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON132054 [Last accessed December 2011]

This website is sponsored by Norgine Pharmaceuticals Ltd


MEGS/2739/DEC11

Norgine Automatic Generic Substitution